Literature DB >> 15479827

The putative zinc finger of the human cytomegalovirus IE2 86-kilodalton protein is dispensable for DNA binding and autorepression, thereby demarcating a concise core domain in the C terminus of the protein.

Jasmin Asmar1, Lüder Wiebusch, Matthias Truss, Christian Hagemeier.   

Abstract

The IE2 86-kDa gene product is an essential regulatory protein of human cytomegalovirus (HCMV) with several functions, including transactivation, negative autoregulation, and cell cycle regulation. In order to understand the physiological significance of each of the IE2 functions, discriminating mutants of IE2 are required that can be tested in a viral background. However, no such mutants of IE2 are available, possibly reflecting structural peculiarities of the large and ill-defined C-terminal domain of IE2. Here, we revisited the C-terminal domain by analyzing IE2 mutants for transactivation, DNA binding, autoregulation, and cell cycle regulation in parallel. We found it to contain an unexpectedly concise core domain (amino acids 450 to 544) that is defined by its absolute sensitivity to any kind of mutation. In contrast, the region adjacent to the core (amino acids 290 to 449) generally tolerates mutations much better. Although it contributes more specific sequence information to distinct IE2 activities, none of the mutations analyzed abolished any particular function. The core is demarcated from the adjacent region by the putative zinc finger region (amino acids 428 to 452). Surprisingly, the deletion of the putative zinc finger region from IE2 revealed that this region is entirely dispensable for any of the IE2 functions tested here in transfection assays. Our work supports the view that the 100 amino acids of the core domain hold the key to most functions of IE2. A systematic, high-density mutational analysis of this region may identify informative mutants discriminating between various IE2 functions that can then be tested in a viral background.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15479827      PMCID: PMC523240          DOI: 10.1128/JVI.78.21.11853-11864.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Activation of proto-oncogenes: an immediate early event in human cytomegalovirus infection.

Authors:  I Boldogh; S AbuBakar; T Albrecht
Journal:  Science       Date:  1990-02-02       Impact factor: 47.728

2.  Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins.

Authors:  C L Malone; D H Vesole; M F Stinski
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

3.  Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains.

Authors:  R M Stenberg; J Fortney; S W Barlow; B P Magrane; J A Nelson; P Ghazal
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

4.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

5.  The IE2 gene products of human cytomegalovirus specifically down-regulate expression from the major immediate-early promoter through a target sequence located near the cap site.

Authors:  M C Pizzorno; G S Hayward
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

6.  NF-kappaB--a potential therapeutic target for inhibition of human cytomegalovirus (re)activation?

Authors:  Susanna Prösch; Regine Wuttke; Detlev H Krüger; Hans-Dieter Volk
Journal:  Biol Chem       Date:  2002-10       Impact factor: 3.915

7.  Human cytomegalovirus immediate-early two protein region involved in negative regulation of the major immediate-early promoter.

Authors:  T W Hermiston; C L Malone; M F Stinski
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

8.  Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site.

Authors:  J M Cherrington; E L Khoury; E S Mocarski
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

9.  Small internal deletions in the human cytomegalovirus IE2 gene result in nonviable recombinant viruses with differential defects in viral gene expression.

Authors:  Elizabeth A White; Charles L Clark; Veronica Sanchez; Deborah H Spector
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  trans-activation and autoregulation of gene expression by the immediate-early region 2 gene products of human cytomegalovirus.

Authors:  M C Pizzorno; P O'Hare; L Sha; R L LaFemina; G S Hayward
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

View more
  9 in total

1.  Human Cytomegalovirus IE2 Protein Disturbs Brain Development by the Dysregulation of Neural Stem Cell Maintenance and the Polarization of Migrating Neurons.

Authors:  Dasol Han; Sung-Hyun Byun; Juwan Kim; Mookwang Kwon; Samuel J Pleasure; Jin-Hyun Ahn; Keejung Yoon
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

2.  The autoregulatory and transactivating functions of the human cytomegalovirus IE86 protein use independent mechanisms for promoter binding.

Authors:  Dustin T Petrik; Kimberly P Schmitt; Mark F Stinski
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

3.  Evidence that the human cytomegalovirus IE2-86 protein binds mdm2 and facilitates mdm2 degradation.

Authors:  Zhigang Zhang; David L Evers; Joseph F McCarville; Jean-Christophe Dantonel; Shu-Mei Huong; Eng-Shang Huang
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

4.  The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein.

Authors:  Arianna Loregian; Beatrice Mercorelli; Giulia Muratore; Elisa Sinigalia; Silvana Pagni; Serena Massari; Giorgio Gribaudo; Barbara Gatto; Manlio Palumbo; Oriana Tabarrini; Violetta Cecchetti; Giorgio Palù
Journal:  Antimicrob Agents Chemother       Date:  2010-03-01       Impact factor: 5.191

5.  Functional properties of the human cytomegalovirus IE86 protein required for transcriptional regulation and virus replication.

Authors:  Siabhon M Harris; Brady Bullock; Elizabeth Westgard; Hua Zhu; Richard M Stenberg; Julie A Kerry
Journal:  J Virol       Date:  2010-06-16       Impact factor: 5.103

6.  Human cytomegalovirus IE1-72 protein interacts with p53 and inhibits p53-dependent transactivation by a mechanism different from that of IE2-86 protein.

Authors:  Eung-Soo Hwang; Zhigang Zhang; Haobin Cai; David Y Huang; Shu-Mei Huong; Chang-Yong Cha; Eng-Shang Huang
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

7.  Transactivation, dimerization, and DNA-binding activity of white spot syndrome virus immediate-early protein IE1.

Authors:  Wang-Jing Liu; Yun-Shiang Chang; Hao-Ching Wang; Jiann-Horng Leu; Guang-Hsiung Kou; Chu-Fang Lo
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

8.  Autorepression of the human cytomegalovirus major immediate-early promoter/enhancer at late times of infection is mediated by the recruitment of chromatin remodeling enzymes by IE86.

Authors:  Matthew Reeves; Jane Murphy; Richard Greaves; Jennifer Fairley; Alex Brehm; John Sinclair
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 9.  Early inhibitors of human cytomegalovirus: state-of-art and therapeutic perspectives.

Authors:  Beatrice Mercorelli; David Lembo; Giorgio Palù; Arianna Loregian
Journal:  Pharmacol Ther       Date:  2011-04-28       Impact factor: 12.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.